Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Avricore Health Inc. V.AVCR

Alternate Symbol(s):  AVCRF

Avricore Health Inc. is committed to becoming a health innovator and applying technologies at the forefront of science to core health issues at the community pharmacy level. The Company’s goal is to empower consumers, patients and pharmacists with innovative technology, products, services and information to monitor and optimize health.


TSXV:AVCR - Post by User

Bullboard Posts
Comment by kingposton Dec 11, 2014 6:23pm
223 Views
Post# 23221589

RE:RE:48 DRUGS TO MARKET

RE:RE:48 DRUGS TO MARKETyes..by definition generics always have competition....West is first east will be next...nph has 4 otc products that r proprietary...without competition also...the company has said approx.100 mill peak.sales for the otc drugs and 100 mill peak sales.for the genetic package estimated sales.... IMO the strength of their business plan will grow rapidly...There is an avalanche of additional drugs coming off patent and the fragmented non efficient Canadian market is ready..
Bullboard Posts